Roche Holding Ltd · SIX:RO
Roche — Investor Day (November 2018)
24 slides from Roche's investor day presentation, Nov 20, 2018
Slide 1: Unlocking The Digital Ecosystem Of Healthcare
Unlocking The Digital Ecosystem Of Healthcare Roche Diagnostics Investor Day Tim M. Jaeger MD PhD MBA 20 November 2018
Slide 2: Introduction – Patients Need Certainty
Introduction – Patients Need Certainty For patients, each diagnosis is an emotional struggle Yearly 14M new cancer cases Survival doubled since 19701 1 https://www.cancerresearchuk.org/health-professional/cancer-statistics/worldwide-cancer/incidence 2
Slide 3: Introduction – Growing Medical Knowledge
Introduction – Growing Medical Knowledge Increasingly difficult for professionals to keep up 1950 50 years 1980 7 years 2010 3.5 years By 2020, medical knowledge will double every 0.2 years or in just 73 days Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116346/ 3
Slide 4: Introduction – Layers Of Complexity In Medicine
Introduction – Layers Of Complexity In Medicine Layers of interdependent data add complexity at various levels Diagnostic Complexity Multi-disciplinary XRAYS &/or LDCT SCANS >8mm LUNG MASS Work Up BIOPSY/Surgical Excision Diagnosis Patient BENIGN Practitioner H&E (HE600) Treatment Complexity Workflo
Slide 5: Introduction – Changes In Healthcare Environment
Introduction – Changes In Healthcare Environment Healthcare undergoing rapid and fundamental change Novel technologies and data Increased understanding More educated and sources entering research as of disease biology empowered patients well as clinic Regulatory environment Global demand Partnersh
Slide 6: Roche Group – What Makes Us Different
Roche Group – What Makes Us Different Unique combination of assets in ONE Roche Diagnostics Pharma Roche uniquely positioned: • Pharma & Diagnostics under one roof Tests Medicines • Excellence in medicine and biology ▼ ▼ Clinical Value-based • Leading portfolio of therapies Decision Support Therapie
Slide 7: Roche Group – Personalised Healthcare Opportunity
Roche Group – Personalised Healthcare Opportunity Leverage data to shift focus towards truly individualised patient care PAST PRESENT FUTURE Blockbuster drugs Companion Diagnostics Personalized healthcare One medication for broad Advanced diagnostics & Individualized treatment & categories of patien
Slide 8: Roche Diagnostics – Clinical Decision Support Opportunity
Roche Diagnostics – Clinical Decision Support Opportunity Clinical Decision Support at the center of care continuum Treatment Decisions Diagnosis Treatment Clinical Decision Clinical Established Support trials therapy option Monitoring / Survivorship 8
Slide 9: Diagnostics Information Solutions (DIS) – Strategy Overview
Diagnostics Information Solutions (DIS) – Strategy Overview Focus on clinical decision support Become leading provider of data-driven and value-based clinical decision support solutions Our Vision for healthcare providers and patients Our Objectives Improve patient outcomes Empower our customers Est
Slide 10: DIS Strategy – Clinical Decision Support Framework
DIS Strategy – Clinical Decision Support Framework Enabled by R&D and supporting value-based care models New IVD Documentation & technologies & standardization of next-gen CDS quality & cost of care Value-based Smarter, more care / Disease efficient R&D Data & Patient Management Analytics outcomes N
Slide 11: DIS Strategy – Clinical Decision Support Elements
DIS Strategy – Clinical Decision Support Elements Enabled by activities in translational science, data and with payors Rapid translation of new discoveries & capability Informed development by Science Clinical Decision Support Supporting Incentivizing value-based provider adoption care of CDS throug
Slide 12: NAVIFY Ecosystem – Decision Support Portfolio Overview
NAVIFY Ecosystem – Decision Support Portfolio Overview Platform with workflow products, apps and value-added services App Ecosystem5 Value-Added Services4 Clinical Decision Support Apps3 Workflow Products2 Core Data Hub Advanced 3rd Party NAVIFY Platform 1 Infrastructure (PHI and deID) Analytics Ser
Slide 13: NAVIFY Ecosystem – NAVIFY Tumor Board Introduction
NAVIFY Ecosystem – NAVIFY® Tumor Board Introduction First commercially available product, launched in 7 markets (EU/US) Supporting oncology care teams to review, collaborate, and align on treatment decisions for patients. A comprehensive dashboard for cancer care teams - integrates all the disparate
Slide 14: NAVIFY Ecosystem – NAVIFY Tumor Board Workflow Study
NAVIFY Ecosystem – NAVIFY Tumor Board Workflow Study Workflow benefits for oncology care teams NAVIFY Tumor Board improves workflow efficiency with shorter preparation time particularly for oncologists.1 1 http://www.jpathinformatics.org/article.asp?issn=2153-3539;year=2018;volume=9;issue=1;spage=26
Slide 15: Patient dashboard
Patient dashboard Disease information Patient treatment history Ultrasound Mammogram Mammogram
Slide 16: NAVIFY Ecosystem – Oncology Workflow
NAVIFY Ecosystem – Oncology Workflow Comprehensive coverage of diagnostic and clinical workflows uPath* NAVIFY NAVIFY Tumor Board CDS Apps Staining Scanning Image mgmt Imaging CDS3 tools EMR4 Tissue dissection NAVIFY Mutation Profiler* Sample handling Tissue analysis CAIR2 Diagnostics Lab Hospital S
Slide 17: NAVIFY Ecosystem – Portfolio Evolution
NAVIFY Ecosystem – Portfolio Evolution Continuously adding functionalities to expand value Beyond 2019 Decision support 2018 ecosystem spanning Single setting, Multiple settings, multiple disease areas single disease area single disease area and settings Workflow products & Disease-specific Comprehe
Slide 18: Commercial – Market Opportunity
Commercial – Market Opportunity Worldwide market opportunity for CDS growing rapidly Electronic Medical Records Practice Management Physician Ordering System Health IT Integration Clinical Healthcare IT Clinical Decision Support Solutions Laboratory Information System Radiology Information System Te
Slide 19: Commercial – Competitive Landscape
Commercial – Competitive Landscape Traditional and non-traditional vendors leveraging respective capabilities Health IT MedTech Technology Startups Market incumbents Tangential players with New entrants leveraging Small startups & specialty with large install-base. large install-base of hospital dee
Slide 20: Commercial – SaaS Business Model
Commercial – SaaS Business Model Speed and scale: create sockets first, revenue follows To get to high customer lifetime value and recurring revenue streams • R&D and M&D investment • Landgrab • Farming Foundational Speed & Increase share Industrialisation/ Experiment Scale of wallet Profit optimiat
Slide 21: Collaboration – GE Healthcare Strategic Partnership
Collaboration – GE Healthcare Strategic Partnership Co-develop and co-market integrated digital diagnostic software products Exclusive strategic partnership Vendor-agnostic software products in In-vitro diagnostics data Clinical Oncology (Roche lead) and In-vivo diagnostics data Acute Care (GEHC lea
Slide 22: Collaboration – Accenture Integration Partnership
Collaboration – Accenture Integration Partnership Connecting disparate clinical information to improve decision making Exclusive strategic partnership Decision support Connecting hospitals to NAVIFY Healthcare providers solutions platform at scale systems Benefits / Synergies Data integration servic
Slide 23: Closing – Unlocking The Digital Healthcare System
Closing – Unlocking The Digital Healthcare System Committed to driving clinical decision support towards an ecosystem Roche uniquely positioned to help navigate increasing complexity in healthcare and deliver on promise of personalised healthcare. Delivering clinical decision support solutions infor
Slide 24: Doing now what patients need next
Doing now what patients need next